Eagle Genomics Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
125
- Latest Deal Type
-
M&A
Eagle Genomics General Information
Description
Developer of a knowledge discovery platform designed to conduct data-intensive research in life sciences. The company's platform provides an easy-to-use intuitive approach for curating, integrating, sharing, analyzing, and valuing scientific data for clinical and molecular studies in life sciences and fields where similar challenges have been addressed, enabling scientist to deliver products and technologies into their respective markets.
Contact Information
Website
www.eaglegenomics.com(Operating Subsidiary)
Corporate Office
- 36-40 York Way
- London N1 9AB
- England, United Kingdom
Corporate Office
- 36-40 York Way
- London N1 9AB
- England, United Kingdom
Eagle Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 17. Merger/Acquisition | 10-Jan-2025 | Completed | Generating Revenue | |||
| 16. Later Stage VC (Series D) | 01-Sep-2023 | Completed | Generating Revenue | |||
| 15. Secondary Transaction - Private | 17-Oct-2022 | Completed | Generating Revenue | |||
| 14. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 13. Later Stage VC (Series A) | 26-Oct-2020 | Completed | Generating Revenue | |||
| 12. Accelerator/Incubator | 12-Nov-2019 | Completed | Generating Revenue | |||
| 11. Accelerator/Incubator | 30-Jul-2019 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series A) | 04-Feb-2019 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 20-Jun-2018 | $1.13M | $4.64M | Completed | Generating Revenue | |
| 8. Accelerator/Incubator | 09-Mar-2018 | $3.51M | Completed | Generating Revenue |
Eagle Genomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 31,048 | $0.012697 | $107.13 | $107.13 | 1x | $107.13 | 7.97% | |
| Ordinary | 9,441 | $0.012697 | $112.33 | $112.33 | 1x | $112.33 | 2.42% |
Eagle Genomics Comparisons
Industry
Financing
Details
Eagle Genomics Competitors (33)
One of Eagle Genomics’s 33 competitors is BC Platforms, a Private Equity-Backed company based in Zurich, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BC Platforms | Private Equity-Backed | Zurich, Switzerland | ||||
| Genotypic Technology | Corporation | Bengaluru, India | ||||
| Novogene | Formerly PE-Backed | Beijing, China | ||||
| Genuity Science | Formerly VC-backed | Dublin, Ireland | ||||
| Strand (Biotechnology) | Formerly VC-backed | Bangalore, India |
Eagle Genomics Signals
Eagle Genomics Former Investors (28)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ACF Investors | Venture Capital | Minority | ||
| Aberdeen Investments (Scotland) | Asset Manager | Minority | ||
| Angel (individual) | Minority | |||
| Anatom Holding | PE/Buyout | Minority | ||
| Angels in Med City | Angel Group | Minority |
Eagle Genomics FAQs
-
When was Eagle Genomics founded?
Eagle Genomics was founded in 2008.
-
Where is Eagle Genomics headquartered?
Eagle Genomics is headquartered in London, United Kingdom.
-
What is the size of Eagle Genomics?
Eagle Genomics has 125 total employees.
-
What industry is Eagle Genomics in?
Eagle Genomics’s primary industry is Biotechnology.
-
Is Eagle Genomics a private or public company?
Eagle Genomics is a Private company.
-
What is Eagle Genomics’s current revenue?
The current revenue for Eagle Genomics is .
-
How much funding has Eagle Genomics raised over time?
Eagle Genomics has raised $42.6M.
-
Who are Eagle Genomics’s investors?
ACF Investors, Aberdeen Investments (Scotland), , Anatom Holding, and Angels in Med City are 5 of 28 investors who have invested in Eagle Genomics.
-
Who are Eagle Genomics’s competitors?
BC Platforms, Genotypic Technology, Novogene, Genuity Science, and Strand (Biotechnology) are some of the 33 competitors of Eagle Genomics.
-
When was Eagle Genomics acquired?
Eagle Genomics was acquired on 10-Jan-2025.
-
Who acquired Eagle Genomics?
Eagle Genomics was acquired by Cmbio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process